Trident Texofab Ltd Financials
Company Logo

Trident Texofab Ltd Financial Statement

Trident Texofab Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue28.52
Operating Expense26.01
Net Profit1.02
Net Profit Margin3.58
Earning Per Share0.72
EBIDTA2.44
Effective Tax Rate11.20

Trident Texofab Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual122.06
Operating Expenses Annual116.58
Operating Profit Annual8.77
Interest Annual4.55
Depreciation1.52
Net Profit Annual2.51
Tax Annual0.07

Trident Texofab Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.16
Cash Flow from Operations-13.72
Cash Flow from Investing-19.92
Cash Flow from Financing36.65
Cash Flow at the End3.16

Trident Texofab Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)6.84
PBIT Margin (%)5.49
PBT Margin (%)4.64
Net PROFIT Margin (%)2.06
Return On Networth / Equity (%)2.61
Return On Networth /Employed (%)9.82
Return On Assets (%)3.68
Total Debt / Equity (X)1.10
Asset Turnover Ratio (%)1.79

Trident Texofab Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual20.09
Total Current Assets Annual73.74
Non Current Assets Annual26.83
Total Shareholders Funds Annual47.24
Total Assets Annual100.58

Trident Texofab Ltd Earning Calls

No Data Availabe

FAQS on Trident Texofab Ltd Financials

As of Oct 5, 2025, Trident Texofab Ltd has a market capitalization of 237.01 Cr. Value Research classifies it as a Small-Cap company.

Yes, Trident Texofab Ltd is not with a debt-to-equity ratio of 0.63.

In FY 2024 , Trident Texofab Ltd recorded a total revenue of approximately 122.06 Cr marking a significant milestone in the company's financial performance.

Trident Texofab Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.7% and 0.1% annually, respectively..

Trident Texofab Ltd's current PE ratio is 94.43.

Trident Texofab Ltd's ROCE averaged 9.7% from the FY ending March 2023 to 2025, with a median of 9.1%. It peaked at 11.7% in March 2023, reflecting strong capital efficiency over the period..

Trident Texofab Ltd's latest EBIT is Rs. 7.13 Cr, surpassing the average EBIT of Rs. 6.26 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions